JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1999; 33:985-990
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, W.-K.
Right arrow Articles by Hammill, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, W.-K.
Right arrow Articles by Hammill, S. C.

CLINICAL STUDIES

Utility of a single-stage isoproterenol tilt table test in adults

A randomized comparison with passive head-up tilt

Win-Kuang Shen, MD, FACC*, Arshad Jahangir, MD*, Douglas Beinborn, RN*, Christine M. Lohse, BS{dagger}, David O. Hodge, MS{dagger}, Robert F. Rea, MD, FACC* and Stephen C. Hammill, MD, FACC*

* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
{dagger} Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

Manuscript received June 11, 1998; revised manuscript received September 16, 1998, accepted December 4, 1998.

Reprint requests and correspondence: Dr. Win-Kuang Shen, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905

OBJECTIVES

This study was conducted to develop a time-efficient tilt table test.

BACKGROUND

Current protocols of tilt table testing are quite time-consuming. This study was designed to assess the diagnostic value, tolerance and procedural time of a single-stage isoproterenol tilt table protocol.

METHODS

A single-stage isoproterenol tilt table test was compared with the passive tilt table test. The study was prospectively designed in a randomized and crossover fashion.

RESULTS

The study population consisted of 111 patients with a history of syncope (mean age 55 ± 20 years). Of the total, 62 patients (56%; 95% confidence interval, 46% to 65%) had a positive vasovagal response during isoproterenol tilt table testing and 35 (32%; 23% to 41%) during passive tilt table testing (p = 0.002). The mean procedural times of the study population were 11.7 ± 3.6 min and 36.9 ± 13.3 min for isoproterenol and passive tilt table testing, respectively (p < 0.001). All patients tolerated single-stage isoproterenol testing. In the 23 control subjects (mean age 34 ± 11 years), the apparent specificities were 91% (72% to 99%) and 83% (61% to 99%) for passive and single-stage tilt table testing, respectively.

CONCLUSIONS

The single-stage isoproterenol tilt table test was more effective in inducing a positive vasovagal response in an adult population than the standard passive tilt table test, and it significantly reduced the procedural time. The increase in positive yield was associated with a moderate decrease in apparent specificity. These observations support the conclusion that single-stage tilt table testing could be a reasonable diagnostic option in patients undergoing syncope evaluation.




This article has been cited by other articles:


Home page
EuropaceHome page
S. Petkar and A. Fitzpatrick
Tilt-table testing: transient loss of consciousness discriminator or epiphenomenon?
Europace, June 1, 2008; 10(6): 747 - 750.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. H. Madrid, J. Ortega, J. G. Rebollo, J. G. Manzano, J. G. Segovia, A. Sanchez, G. Pena, and C. Moro
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 554 - 559.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Sheldon and S. Rose
Components of clinical trials for vasovagal syncope
Europace, January 1, 2001; 3(3): 233 - 240.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
A. M. Fenton, S. C. Hammill, R. F. Rea, P. A. Low, and W.-K. Shen
Vasovagal Syncope
Ann Intern Med, November 7, 2000; 133(9): 714 - 725.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W.-K. Shen, P. A. Low, R. F. Rea, C. M. Lohse, D. O. Hodge, and S. C. Hammill
Distinct hemodynamic profiles in patients with vasovagal syncope: a heterogeneous population
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1470 - 1477.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.